Johnston, Ethan, MD

Dr. Ethan Johnston is a current PGY3 Psychiatry Resident at the University of Missouri- Kansas City. Dr. Johnston did his undergraduate and medical doctoral training at the University of Missouri Kansas City, graduating in 2021. He is currently the Residency Association President and Class Representative for the Program Evaluation Committee, and has been selected as the Chief Resident for the upcoming academic year. Dr. Johnston’s research and presentation portfolio include the following topics: Electroconvulsive Therapy in the Geriatric Population, Malingering of Psychotic Symptoms, Separation Anxiety Disorder in Children Mistaken for Autism Spectrum Disorder, and Involuntary Movement Disorders. Dr. Johnston has a strong interest in LGBTQ+ care with his recent Grand Rounds Presentation “Psychiatry for All. Considerations in psychiatric care for the gender diverse”. Dr. Johnston also has a passion for teaching, currently pursuing a Masters of Health Professions Education.

Presentation(s):

Psychiatry for All: Considerations in Psychiatric Care for the Gender Diverse

Room Parasol I


Speaker(s)

Description

The transgender and gender nonconforming community faces numerous barriers. Structural, interpersonal, and individual stigmas against this community have led to health disparities, many of which are particularly relevant to the psychiatric community. Rates of most mental health diagnoses are much higher in the transgender community than in the general population, including mood disorders, psychotic disorders, and substance use disorders, giving psychiatric clinicians ample opportunity to intervene for the good of our patients. Provider discrimination, historical stigma from the psychiatric community, and previous poor experiences from medical providers lead to continued hesitancy to best help this population. In this presentation, we explore literature surrounding this topic, understand current views from the American Psychiatric Association on the transgender community, and evaluate ways that we can help this community. We define appropriate vocabulary, explore hormone replacement therapy and surgical options, and evaluate letters of support. We review the national transgender survey outlining current trends amongst the transgender community and what we as mental health providers can do to advocate for our patients. There is evidence behind hormone replacement therapy and gender affirming surgeries in this community, and as providers with a very high likelihood of encountering several members of this community in our practices, this presentation is a call for action to provide appropriate care, referrals, and advocacy for this patient population.

Objectives

  • Discuss the historical stigmatization of gender diverse individuals as related to the psychiatric community
  • Analyze the prevalence of mental health disorders in this community, current thoughts towards psychiatry from transgender and gender nonconforming individuals and how we can improve
  • Integrate the role of a mental health provider in aiding those seeking gender affirming care

Psilocybin use in Psychiatric Disorders

Room Parasol I


Speaker(s): 

Ali Mahmoud, MD

Description: 

Recent researches have proven that psilocybin has a wide rage of therapeutic benefits especially in Treatment- Resistant depression. FDA has recently gave psilocybin a ” breakthrough therapy designation” for treatment-resistant depression. In my presentation will talk in detail about psilocybin pharmacology, pharmacokinetics and will give overview on its therapeutic benefits based on recents studies.

Objectives

  • Obtain knowledge on history of psychedelic therapy from the past to the present time
  • Define psilocybin pharmacology
  • Discuss therapeutic benefits of psilocybin especially in treatment resistant depression
  • Discuss “assistant therapy ” and its phases

Mahmoud, Ali, MD

I am a PGY-4 psychiatry resident at University of Missouri- Columbia program. I obtained my Bachelor degree in Medicine and Surgery from University of Alexandria in Egypt. I did my neuropsychiatry residency training in Alexandria /Egypt from 2005-2008. I also did another 5-year psychiatry residency training in Kuwait ( 2014-2019). I will be talking about Psilocybin use in psychiatric disorders. I did my grand round on this topic last year. You can access this presentation here : https://www.youtube.com/watch?v=iYvADrq9zHw.

Presentation(s):

Beck, Niels, PhD

Niels C Beck received his PhD in Clinical Psychology from St. Louis University. Currently, he works as a consultant to the State Hospital in Fulton and assists with a variety of applied research and quality improvement projects. Previously, he was a tenured full professor at the University of Missouri Medical School, where he served as vice-chair of the Department of Psychiatry. Dr. Beck and his colleagues at Fulton have done work related to inpatient aggression since the early 1990s.

Presentation(s):

Choate, Alexandria, MA

Allie Choate is a doctoral candidate in clinical psychology at the University of South Florida. She is currently completing her pre-doctoral internship at Fulton State Hospital. Her research focuses on understanding developmental mechanisms that foster the development of borderline personality disorder (BPD) traits, as well as their co-occurrence with other forms of psychopathology and problematic behavior, such as substance use and aggression.
 

Presentation(s):

Evaluating the Effects of Environmental and Therapeutic Interventions on Inpatient Aggression Contagion

Room Parasol I


Speaker(s)

Description

The presentation will focus on discussing the historical context of aggression contagion within inpatient forensic settings. Research at the Fulton State Hospital has identified that aggressive incidents are often “contagious,” meaning incidents are not randomly spread across the year but clustered temporally. This presentation will examine the presence of aggression contagion within all programs at Fulton State Hospital. Additionally, the presentation will describe the clinical presentations associated with aggression contagion. Lastly, presenters will provide examples of aggression contagion and interventions utilized to reduce the impact of this phenomenon on aggression within inpatient units.

Objectives

  • Define aggression contagion within inpatient forensic settings.
  • Identify patterns of aggression contagion based on clinical presentation.
  • Identify interventions that target aggression contagion.

Violent Impulsivity in the Chronic Inpatient Unit

Speaker(s):

Jahan, Azmi, MD

Presentation:

Analyzing behavioral patterns in treating impulsiveness and aggression on the chronic inpatient unit.

Objectives:

  1. Identify medication properties that would effectively treat impulsivity
  2. Familiarize with impulsivity factors and its association with substance abuse
  3. Identify treatment challenges when selecting treatment regimen
  4. Identify medications, which provides effective results in treating violent impulsive behavior, while being familiar with the adverse side effects

Jahan, Azmi, MD

Dr. Azmi Jahan completed his Bachelor’s of Arts from Georgia State University and went further to obtain his Medical Degree from St. James School of Medicine. He is currently completing his last year of Psychiatry residency training at UMKC. His presentation focuses on analyzing medications and/or additional factors that his patient responded to in treating aggression.

Presentation(s): 

Violent Impulsivity in the Chronic Inpatient Unit


 

 

Reducing Burnout and Increasing Empathy in Psychiatry Healthcare Workers Using Balint Groups

Speaker(s):

Oyetunji, Aderonke, MD

Presentation:

This is a powerpoint presentation about a QI project on Balint groups as a clinical intervention for burnout among mental healthcare workers particularly psychiatrists and Mental Health Caseworkers.
  

It analyzes the use of certain measures in detecting burnout and determining if the use of Balint intervention decreases burnout, increases empathy and job satisfaction using pre and post measure results following this intervention.

Objectives:

  1. Understand the impact of burnout on mental healthcare workers
  2. Identify the use of Balint as a clinical intervention for burnout
  3. Measure the benefit of a burnout measure as a useful tool in a Balint intervention